3//SEC Filing
ARCH Venture Partners VIII, LLC 3
Accession 0001209191-18-056602
CIK 0001581280other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 7:29 PM ET
Size
20.8 KB
Accession
0001209191-18-056602
Insider Transaction Report
Form 3
ARCH Venture Partners VIII, LLC
10% Owner
Holdings
- (indirect: By ARCH Venture Fund VIII Overage, L.P.)
Series D Preferred Stock
→ Common Stock (894,146 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series C Preferred Stock
→ Common Stock (266,776 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series B Preferred Stock
→ Common Stock (718,275 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series D Preferred Stock
→ Common Stock (224,726 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series A Preferred Stock
→ Common Stock (1,182,645 underlying)
NELSEN ROBERT
10% Owner
Holdings
- (indirect: By Arch Venture Fund VII, L.P.)
Series A Preferred Stock
→ Common Stock (1,182,645 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series C Preferred Stock
→ Common Stock (266,776 underlying) - (indirect: By ARCH Venture Fund VIII Overage, L.P.)
Series D Preferred Stock
→ Common Stock (894,146 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series B Preferred Stock
→ Common Stock (718,275 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series D Preferred Stock
→ Common Stock (224,726 underlying)
Arch Venture Fund VII LP
10% Owner
Holdings
- (indirect: By Arch Venture Fund VII, L.P.)
Series A Preferred Stock
→ Common Stock (1,182,645 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series C Preferred Stock
→ Common Stock (266,776 underlying) - (indirect: By ARCH Venture Fund VIII Overage, L.P.)
Series D Preferred Stock
→ Common Stock (894,146 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series B Preferred Stock
→ Common Stock (718,275 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series D Preferred Stock
→ Common Stock (224,726 underlying)
ARCH Venture Partners VII, L.P.
10% Owner
Holdings
- (indirect: By Arch Venture Fund VII, L.P.)
Series A Preferred Stock
→ Common Stock (1,182,645 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series B Preferred Stock
→ Common Stock (718,275 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series C Preferred Stock
→ Common Stock (266,776 underlying) - (indirect: By ARCH Venture Fund VIII Overage, L.P.)
Series D Preferred Stock
→ Common Stock (894,146 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series D Preferred Stock
→ Common Stock (224,726 underlying)
ARCH Venture Partners VII, LLC
10% Owner
Holdings
- (indirect: By Arch Venture Fund VII, L.P.)
Series A Preferred Stock
→ Common Stock (1,182,645 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series C Preferred Stock
→ Common Stock (266,776 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series D Preferred Stock
→ Common Stock (224,726 underlying) - (indirect: By ARCH Venture Fund VIII Overage, L.P.)
Series D Preferred Stock
→ Common Stock (894,146 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series B Preferred Stock
→ Common Stock (718,275 underlying)
BYBEE CLINTON
10% Owner
Holdings
- (indirect: By Arch Venture Fund VII, L.P.)
Series D Preferred Stock
→ Common Stock (224,726 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series C Preferred Stock
→ Common Stock (266,776 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series A Preferred Stock
→ Common Stock (1,182,645 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series B Preferred Stock
→ Common Stock (718,275 underlying) - (indirect: By ARCH Venture Fund VIII Overage, L.P.)
Series D Preferred Stock
→ Common Stock (894,146 underlying)
ARCH Venture Fund VIII Overage, L.P.
10% Owner
Holdings
- (indirect: By Arch Venture Fund VII, L.P.)
Series B Preferred Stock
→ Common Stock (718,275 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series D Preferred Stock
→ Common Stock (224,726 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series A Preferred Stock
→ Common Stock (1,182,645 underlying) - (indirect: By Arch Venture Fund VII, L.P.)
Series C Preferred Stock
→ Common Stock (266,776 underlying) - (indirect: By ARCH Venture Fund VIII Overage, L.P.)
Series D Preferred Stock
→ Common Stock (894,146 underlying)
Footnotes (4)
- [F1]The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock have no expiration date and automatically convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering.
- [F2]The shares are directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- [F3]Clinton Bybee and Robert Nelsen are managing directors of ARCH VII LLC and AVP GPLLC, and they may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Messrs. Bybee and Nelsen disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- [F4]The shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("AVP GPLLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. AVP GPLLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001616165
Filing Metadata
- Form type
- 3
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 7:29 PM ET
- Size
- 20.8 KB